 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Aceprometazine" – news ·newspapers ·books ·scholar ·JSTOR(February 2020) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal and fecal |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.033.315 |
| Chemical and physical data | |
| Formula | C19H22N2OS |
| Molar mass | 326.46 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Aceprometazine (INN) is aphenothiazine derivativeprescription drug withneuroleptic andanti-histamine properties It is not widely prescribed, and may be associated with drug-induced Parkinsonism.[1] It may be used in combination withmeprobamate for the treatment ofsleep disorders. This combination is available inFrance under the trade nameMepronizine.
It is structurally related to the phenothiazine derivative veterinary drugacepromazine.
Note: The reason for the rearrangement in the sidechain between the precursor and the product are on account of amethadone-typeaziridine.
2-Acetylphenothiazine [6631-94-3] (1)2-Chloropropyldimethylamine [108-14-5] (2)
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information. |
